Endexx Corporation Issues Correction and Highlights Revenue Growth
Endexx (OTC: EDXC) has issued a correction to its Q2 2024 financial report and highlighted significant revenue growth. The company clarified that the previously reported Q2 2024 revenue of $3,275,735 was actually for the six-month period ending March 31, 2024. The correct Q2 2024 revenue (three months ending March 31, 2024) is $2,181,012.
Despite the reporting error, Endexx achieved notable financial results:
- Revenue of $3,275,735 for the six-month period ending March 31, 2024
- Gross profit of $1,246,677 for Q2 2024
- Net income of $506,837 for Q2 2024, a significant improvement from the previous quarter's net loss of $828,902
Interim CEO Brad Listermann emphasized the company's commitment to transparency and continued focus on delivering value through innovative products and strategic market expansion.
Endexx (OTC: EDXC) ha emesso una correzione al suo rapporto finanziario del secondo trimestre del 2024, evidenziando una significativa crescita dei ricavi. L'azienda ha chiarito che i ricavi precedentemente riportati per il secondo trimestre del 2024, pari a $3,275,735, si riferivano in realtà al periodo di sei mesi conclusosi il 31 marzo 2024. I corretti ricavi per il secondo trimestre del 2024 (tre mesi conclusi il 31 marzo 2024) sono $2,181,012.
Nonostante l'errore di reporting, Endexx ha raggiunto risultati finanziari notevoli:
- Ricavi di $3,275,735 per il periodo di sei mesi terminato il 31 marzo 2024
- Utile lordo di $1,246,677 per il secondo trimestre del 2024
- Utile netto di $506,837 per il secondo trimestre del 2024, un miglioramento significativo rispetto alla perdita netta di $828,902 del trimestre precedente
Il CEO ad interim Brad Listermann ha sottolineato l'impegno dell'azienda verso la trasparenza e il continuo focus nel fornire valore attraverso prodotti innovativi ed espansione strategica nel mercato.
Endexx (OTC: EDXC) ha emitido una corrección a su informe financiero del segundo trimestre de 2024 y ha destacado un crecimiento significativo en los ingresos. La compañía aclaró que los ingresos reportados anteriormente para el segundo trimestre de 2024, de $3,275,735, correspondían en realidad al período de seis meses finalizado el 31 de marzo de 2024. Los ingresos correctos del segundo trimestre de 2024 (tres meses finalizados el 31 de marzo de 2024) son $2,181,012.
A pesar del error de reporte, Endexx logró resultados financieros notables:
- Ingresos de $3,275,735 para el período de seis meses finalizado el 31 de marzo de 2024
- Ganancia bruta de $1,246,677 para el segundo trimestre de 2024
- Ingreso neto de $506,837 para el segundo trimestre de 2024, una mejora significativa respecto a la pérdida neta de $828,902 del trimestre anterior
El CEO interino Brad Listermann enfatizó el compromiso de la compañía con la transparencia y el enfoque continuo en ofrecer valor a través de productos innovadores y expansión estratégica en el mercado.
Endexx (OTC: EDXC)는 2024년 2분기 재무 보고서에 대한 수정 사항을 발표하고 상당한 수익 성장을 강조했습니다. 회사는 이전에 보고된 2024년 2분기 수익 $3,275,735가 실제로 2024년 3월 31일 기준 6개월 동안의 기간에 해당한다고 명확히 했습니다. 2024년 2분기 올바른 수익(2024년 3월 31일 기준 3개월)은 $2,181,012입니다.
보고 오류에도 불구하고 Endexx는 눈에 띄는 재무 결과를 달성했습니다:
- 2024년 3월 31일 기준 6개월 동안의 수익 $3,275,735
- 2024년 2분기 총 이익 $1,246,677
- 2024년 2분기 순이익 $506,837로, 이전 분기의 순손실 $828,902에서 상당한 개선을 나타냅니다
임시 CEO 브래드 리스터만은 회사를 향한 투명성에 대한 약속과 혁신적인 제품 및 전략적 시장 확장을 통해 가치를 제공하려는 지속적인 집중을 강조했습니다.
Endexx (OTC: EDXC) a émis une correction à son rapport financier du deuxième trimestre 2024 et a mis en évidence une croissance significative des revenus. L'entreprise a précisé que le revenu précédemment rapporté pour le deuxième trimestre 2024, s'élevant à $3,275,735, concernait en réalité une période de six mois se terminant le 31 mars 2024. Le revenu correct pour le deuxième trimestre 2024 (trois mois se terminant le 31 mars 2024) est de $2,181,012.
Malgré l'erreur de reporting, Endexx a réalisé des résultats financiers notables :
- Revenus de $3,275,735 pour la période de six mois se terminant le 31 mars 2024
- Bénéfice brut de $1,246,677 pour le deuxième trimestre 2024
- Bénéfice net de $506,837 pour le deuxième trimestre 2024, une amélioration significative par rapport à la perte nette de $828,902 du trimestre précédent
Le PDG par intérim Brad Listermann a souligné l'engagement de l'entreprise envers la transparence et la poursuite de son objectif de fournir de la valeur à travers des produits innovants et une expansion stratégique sur le marché.
Endexx (OTC: EDXC) hat eine Korrektur seines Finanzberichts für das 2. Quartal 2024 herausgegeben und ein signifikantes Umsatzwachstum hervorgehoben. Das Unternehmen stellte klar, dass der zuvor gemeldete Umsatz für das 2. Quartal 2024 in Höhe von $3,275,735 tatsächlich für den sechsmonatigen Zeitraum bis zum 31. März 2024 galt. Der korrekte Umsatz für das 2. Quartal 2024 (drei Monate bis zum 31. März 2024) beträgt $2,181,012.
Trotz des Berichtfehlers erzielte Endexx bemerkenswerte finanzielle Ergebnisse:
- Umsatz von $3,275,735 für den sechsmonatigen Zeitraum bis zum 31. März 2024
- Bruttoergebnis von $1,246,677 für das 2. Quartal 2024
- Nettoeinkommen von $506,837 für das 2. Quartal 2024, eine signifikante Verbesserung im Vergleich zum Nettoverlust des vorhergehenden Quartals von $828,902
Der interimistische CEO Brad Listermann betonte das Engagement des Unternehmens für Transparenz und die fortwährende Fokussierung auf die Bereitstellung von Wert durch innovative Produkte und strategische Markterweiterung.
- Revenue growth to $3,275,735 for the six-month period ending March 31, 2024
- Gross profit of $1,246,677 for Q2 2024
- Net income of $506,837 for Q2 2024, reversing previous quarter's net loss
- Incorrect financial reporting in the initial Q2 2024 Shareholder Report
CAVE CREEK, AZ, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Endexx Corporation (OTC: EDXC), a leading provider of innovative plant-based health and wellness products, today issued a correction to its previously reported financial results and highlighted the significant revenue growth achieved in recent months.
Correction to Financial Report
In the Q2 2024 Shareholder Report, the revenue for Q2 2024 was incorrectly stated as
Financial Highlights
Despite the initial reporting error, Endexx Corporation is pleased to announce:
1. Revenue Growth: The company achieved a revenue of
2. Gross Profit: The gross profit for Q2 2024 was
3. Net Loss Reduction: The net income for Q2 2024 was
"We are committed to maintaining transparency and accuracy in our financial reporting," said Brad Listermann, Interim CEO of Endexx Corporation. "We apologize for any confusion caused by the reporting error and are pleased to highlight our continued growth and financial improvements. Our focus remains on delivering value to our shareholders through innovative products and strategic market expansion."
About Endexx Corporation
Endexx Corporation develops and distributes all-natural, plant-derived wellness products and topical skincare products. Its products, ranging from balms, creams, lotions, kinds of butter, masks, scrubs, and oils, are aimed at promoting healthy skin and grooming wellness. The science behind these products involves a decade of clinical research, ensuring functional formulations with ingredients for optimal absorption and skin health support. www.endexx.com
About HYLA
HYLA, a division of Endexx, markets proprietary non-nicotine, guarana, and L-Dopa-based vape products in various flavors. The HYLA device is a first-of-its-kind non-nicotine vape product in the United States, offering up to 4,500 puffs per device. HYLA is currently distributed in 10 countries, with distribution agreements in an additional nine countries. www.tryhyla.com
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as “estimate,” “commit,” “target,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend,” “potential,” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements.
Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included in “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission.
Contact:
Endexx Corporation
IR@Endexx.com
424-250-0042
www.endexx.com
www.cbdunlimited.com
www.tryhyla.com
FAQ
What was Endexx 's (EDXC) corrected Q2 2024 revenue?
How much revenue did Endexx (EDXC) generate in the six months ending March 31, 2024?
What was Endexx 's (EDXC) gross profit for Q2 2024?
How did Endexx 's (EDXC) net income in Q2 2024 compare to the previous quarter?
